Center for Cancer Biology Research

$2,174,863P20FY2015GMNIH

Sanford Research/Usd, Fargo SD

Investigators

Linked publications & trials

Paper 39763973 Paper 39738291 Paper 39513004 Paper 39302290 Paper 39253487 Paper 39038611 Paper 38798572 Paper 38746130 Paper 38683248 Paper 38187776 Paper 38027148 Paper 37905135 Paper 37305926 Paper 37256926 Paper 37213306 Paper 37163587 Paper 37029785 Paper 36932059 Paper 36524414 Paper 36323780 Paper 36100791 Paper 35724928 Paper 35692423 Paper 35626103 Paper 35588002 Paper 35554490 Paper 35406526 Paper 35347121 Paper 35337019 Paper 35322202 Paper 35312941 Paper 35269487 Paper 35204717 Paper 35139372 Paper 35045249 Paper 35024571 Paper 34788623 Paper 34761479 Paper 34593608 Paper 34439353 Paper 33860007 Paper 33673574 Paper 33665223 Paper 33323783 Paper 33225249 Paper 33068914 Paper 33042024 Paper 33015012 Paper 33010819 Paper 32719489 Paper 32704025 Paper 32676162 Paper 32610529 Paper 32601357 Paper 32595828 Paper 32536767 Paper 32479189 Paper 32474964 Paper 32357910 Paper 32212206 Paper 32210076 Paper 32083311 Paper 32074109 Paper 32046449 Paper 31811832 Paper 31402305 Paper 31331814 Paper 31093886 Paper 31088834 Paper 31068677 Paper 31003747 Paper 30941174 Paper 30936178 Paper 30665444 Paper 30613366 Paper 30513596 Paper 30385778 Paper 30340091 Paper 30327461 Paper 30297705 Paper 30289596 Paper 30107089 Paper 29924910 Paper 29649529 Paper 29577064 Paper 29386014 Paper 29307697 Paper 29250330 Paper 29208685 Paper 29166372 Paper 29099739 Paper 28988715 Paper 28746835 Paper 28669593 Paper 28637768 Paper 28630288 Paper 28490517 Paper 28475599 Paper 28442586 Paper 28371199

Abstract

This is a proposal to establish a Center of Biomedical Research Excellence (COBRE) focusing on Cancer Biology with emphasis on the identification, functional characterization, and targeting of tumor specific markers and antigens. Our center will use cell and molecular biology, immunology, nanoparticle technology, and animal models to examine the development, detection, and treatment of human cancer. Five research projects are included. The goals of Project 1 (Meena Jaggi, PhD) are to understand the effects of protein kinase Dl on (3- catenin-mediated signaling and to determine if PKD1 expression influences tumor progression through this pathway. For Project 2 (Kristi Egland, PhD) a large number of membrane and secreted proteins that are expressed at elevated levels in prostate cancer cells were identified. This information will be used to develop a new diagnostic test for prostate cancer that detects autoantibodies in patient serum. Project 3 (Satoshi Nagata, PhD) will develop a panel of monoclonal antibodies to surface antigens that are highly expressed in B cell malignancies. These antibodies will be tested for their potential use in immunotherapies. Project 4 (Subhash Chauhan, PhD) will develop novel methods of treatment and drug delivery for pancreatic cancer. The goal will be to combine radioimmunotherapy and nanoparticle technology for highly specific delivery of cytotoxic compounds. Project 5 (William Spanos, MD) will focus on the role of the immune response in tumor clearance following treatment of head and neck squamous cell carcinoma. A strong mentoring plan will take advantage of the experience of an outstanding group of senior faculty with active research programs. Mentors will provide guidance for research design, manuscript preparation, grant applications, and other crucial aspects of career development. An EAC consisting of five internationally recognized scientists with broad experience in basic, translational, and clinical research has been assembled. Research capabilities will be supported by core facilities in Molecular Pathology, Flow Cytometry, Tumor Biology, and Imaging. We will recruit 3 high quality junior investigators and 1 established investigator. We will train students and post-doctoral fellows, support a seminar series, and fund pilot research projects in the field of cancer research.

View original record on NIH RePORTER →